Guided Therapeutics (GTHP) Return on Assets (2012 - 2025)

Guided Therapeutics (GTHP) has 14 years of Return on Assets data on file, last reported at 0.03% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets fell 1.0% year-over-year to 0.03%; the trailing twelve-month figure through Dec 2025 stood at 0.03% (down 1.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Assets declined to 0.03% in Q4 2025, from 0.03% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q2 2021 to a low of 0.03% in Q4 2025.
• A 5-year average of 0.02% and a median of 0.02% in 2024 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 6 bps in 2021, while the deepest fall reached 3 bps in 2021.
• Tracing GTHP's Return on Assets over 5 years: stood at 0.01% in 2021, then slipped by 18 bps to 0.01% in 2022, then sank by 64 bps to 0.02% in 2023, then grew by 6 bps to 0.02% in 2024, then tumbled by 56 bps to 0.03% in 2025.
• Business Quant data shows GTHP's Return on Assets at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.03% in Q2 2025.